Richard C Adams - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Richard C Adams

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Advanced Drug Delivery Reviews|February 14, 2004

Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs)Andre S Raw, M Scott Furness, Devinder S Gill, et al.

The Journal of Urology|December 14, 2004

Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunctionIsrael Franco, Mark Horowitz, Richard Grady, et al.

Pharmaceutical Research|May 13, 2003

Scientific considerations of pharmaceutical solid polymorphism in abbreviated new drug applicationsLawrence X Yu, M Scott Furness, Andre Raw, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Advanced Drug Delivery Reviews|February 14, 2004

Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs)Andre S Raw, M Scott Furness, Devinder S Gill, et al.

The Journal of Urology|December 14, 2004

Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunctionIsrael Franco, Mark Horowitz, Richard Grady, et al.

Pharmaceutical Research|May 13, 2003

Scientific considerations of pharmaceutical solid polymorphism in abbreviated new drug applicationsLawrence X Yu, M Scott Furness, Andre Raw, et al.

Pageof 2